Clinical trial
Determination of the Effect of 13C-Spirulina Nitrogen Content on In-vivo 13C-Spirulina Gastric Emptying Breath Test (GEBT) Results
NCT04635306 is registered in ClinicalTrials.gov with Cairn Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Effect of 13C-Spirulina Nitrogen Content on In-vivo 13C-Spirulina Gastric Emptying Breath Test (GEBT) Results
- Lead sponsor
- Cairn Diagnostics
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 21, 2020
- Completion date
- June 25, 2021
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.